¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÏÇÐȸ Á¦2ȸ AACR(American Association for Cancer Research)-KCA(Korean Cancer Association) Joint Conference on Precision Medicine in Solid Tumors ¹× Á¦24Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 1 : 2021-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѾÏÇÐȸ Á¦2ȸ AACR(American Association for Cancer Research)-KCA(Korean Cancer Association) Joint Conference on Precision Medicine in Solid Tumors ¹× Á¦24Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 1 : 2021-11-11
±³À°ÀÏÀÚ : 2021-11-11
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ) ¹× ¼­¿ï·Ôµ¥È£ÅÚ 2Ãþ Å©¸®½ºÅ»º¼·ë 2°³·ë  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦2ȸ AACR(American Association for Cancer Research)-KCA(Korean Cancer Association) Joint Conference on Precision Medicine in Solid Tumors ¹× Á¦24Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 1 
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer2@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 9 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 300,000¿ø      
ºñ°í 1. »çÀüµî·Ï: 1) ȸ¿ø 10¸¸¿ø, 2) ºñȸ¿ø 15¸¸¿ø, 3) ¾÷ü¹×¿¬±¸¼Ò 20¸¸¿ø, 4) Trainee ¹«·á2. ÀϹݵî·Ï: 1) ȸ¿ø 20¸¸¿ø, 2) ºñȸ¿ø 25¸¸¿ø, 3) ¾÷ü¹×¿¬±¸¼Ò 30¸¸¿ø, 4) Trainee 3¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 Room A 08:10~08:40 Progress in targeting KRAS(kirsten rat sarcoma viral oncogene homolog) directly  Frank McCormick(UCSF Helen Diller Family Comprehensive Cancer Center) 
È޽Ġ11-11  08:40~09:00 È޽Ġ () 
±³À°½Ã°£ 11-11 Room A 09:00~09:25 Immune approaches to cancer therapy: Building on lessons checkpoint blockade  Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center) 
±³À°½Ã°£ 11-11 Room A 09:25~09:50 Next generation immunotherapy beyond anti-PD-1 (programmed cell death-1) and CTLA4 (cytotoxic T-lymphocyte-associated protein 4)  ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 Room A 09:50~10:15 Academic clinical trials of CAR T (chimeric antigen receptor-T) cell therapy for cancer  Marcela V. Maus(Harvard Medical School) 
±³À°½Ã°£ 11-11 Room A 10:15~10:40 To be announced  ÀÓ¼®¾Æ(¼­¿ïÀÇ´ë) 
È޽Ġ11-11  10:40~11:00 È޽Ġ () 
±³À°½Ã°£ 11-11 Room A 11:00~11:25 Proteomic characterization of the RAS (renin angiotensin system) secretome  Peter K. Jackson(Stanford University) 
±³À°½Ã°£ 11-11 Room A 11:25~11:50 Mobilization of LINE-1 retrotransposons in colorectal epithelium  ÁÖ¿µ¼®(KAIST) 
±³À°½Ã°£ 11-11 Room A 11:50~12:15 Systematic elucidation and pharmacological targeting of non-oncogene dependencies in single cells  Andrea Califano(Columbia University) 
±³À°½Ã°£ 11-11 Room A 12:15~12:40 Gastric cancer proteogenomics  È²´ëÈñ(¼­¿ï´ë) 
½Ä»ç 11-11  12:40~13:10 ½Ä»ç  () 
±³À°½Ã°£ 11-11 Room A 13:10~13:40 Transforming the treatment paradigm in GC(gastric cancer)/ GEJ(gastroesophageal junction)/ EAC(esophageal adenocarcinoma) 1L: Nivolumab + Chemotherapy  ¹Ú¼÷·Ã(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-11 Room A 13:40~14:10 Innovative treatment of aRCC(advanced renal cell carcinoma) 1L with superior long-term efficacy and tolerability: Nivolumab + Ipilimumab  ¹ÚÀαÙ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-11 Room B 13:10~13:30 Pembrolizumab+Lenvatinib: The optimal combination treatment for advanced solid tumors  ±è¹Îȯ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room B 13:30~13:50 Enable comprehensive genomic profiling liquid biopsy  ÀåÀÚÇö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11-11 Room B 13:50~14:10 Larotrectinib – A new ive TRK(tropomyosin receptor kinase) inhibitor for NTRK(neurotrophic tyrosine receptor kinase) fusion-positive cancer patients  ÀÌ´ëÈ£(¿ï»êÀÇ´ë) 
È޽Ġ11-11  14:10~14:30 È޽Ġ () 
±³À°½Ã°£ 11-11 Room A 14:30~15:30 Proffered Papers Session  ¹ÌÁ¤() 
È޽Ġ11-11  15:30~15:50 È޽Ġ () 
±³À°½Ã°£ 11-11 Room A 15:50~16:15 Breast cancer  ÀÌÁ¤¾ð(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 Room A 16:15~16:40 Current issues in neoadjuvant therapy of lung cancer  ³ª±ÇÁß(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-11 Room A 16:40~17:05 Surgery after neoadjuvant therapy for locally advanced or borderline resectable pancreatic cancer  ¼Û±âº´(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-11 Room B 15:50~16:15 Medical image analysis using deep learning  ¹Ú»óÇö(DGIST) 
±³À°½Ã°£ 11-11 Room B 16:15~16:40 AI(artificial intelligence) application in cancer imaging  ¼­Áعü(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-11 Room B 16:40~17:05 AI(artificial intelligence) application in pathology  ±è¼®ÈÖ(¾ÆÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Ä¥°î°æºÏ´ëÇб³º´¿ø È£½ºÇǽº¿ÏÈ­ÀÇ·áÁ¾»çÀÚ º¸¼ö±³À° : 2021-11-12
´ÙÀ½±Û 2021³â ´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ ÀüºÏÁöȸ Ãß°èÇмú´ëȸ : 2021-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 0 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 0 2024-05-27
20773 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç(1ÀÏÂ÷) : 2024-06-13 0 1 2024-05-27
20772 ´ë±¸ 2024 Á¦2Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-06-13 0 3 2024-05-27
20771 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-13 0 4 2024-05-27
20770 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-13 0 2 2024-05-27
20769 ¼­¿ï 2024³â ±Ýõ±¸ÀÇ»çȸ 1Â÷ ¿¬¼ö±³À°(¿ì¿ïÁõ ¾àÁ¦, ÇǺÎÁúȯ, CBC¿Í LFT, À§¿°) : 2024-06-12 0 0 2024-05-27
20768 ¼­¿ï 2024 Á¦3ȸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï¡¤Èñ±ÍÁúȯ ±Øº¹»ç¾÷ ¿¬±¸ÀÚ SKILL-UP Workshop : 2024-06-12 0 0 2024-05-27
20767 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦78Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-11 0 0 2024-05-27
20766 ±¤ÁÖ Á¦180Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2024-06-11 0 2 2024-05-27
20765 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦362Â÷ ¿ù·ÊÇмúȸ : 2024-06-11 0 10 2024-05-27
20764 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-11 0 5 2024-05-27
20763 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ»ç) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-06-11 0 5 2024-05-27
20762 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Á¦ 32ȸ Á¤±â Áý´ãȸ : 2024-06-10 0 5 2024-05-27
20761 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø Á¦16ȸ KOALA Symposium 2024 : 2024-06-09 0 1 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷